Health Products

Soliris (2014-06-06)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
00015A
Recalling Firm
Alexion Pharma Canada Corp
400 Applewood Crescent, Suite 120
Vaughan
Ontario
CANADA
Marketing Authorization Holder
Alexion Pharma International, SARL
34 Avenue du Tribunal Federal
SolirisSolutionDIN 02322285Eculizumab - 10 mg/ml

Introduction

Recalled Products

Soliris

Reason

Due to the presence of visible particles in a limited number of vials from a lot of Soliris which was distributed in another market.  Lots which were manufactured using the same process are being recalled.

Depth of distribution

Hospitals/Pharmacies across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime